{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-26-051041","form_type":"8-K","ticker":"DNA","cik":"0001830214","company_name":"Ginkgo Bioworks Holdings, Inc.","filed_at":"2026-07-30T20:06:06+00:00","discovered_at":"2026-07-30T20:07:00.227927+00:00","generated_at":"2026-07-30T20:07:34.148728+00:00","sec_items":["7.01","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Ginkgo Bioworks schedules Q2 2026 earnings call for August 5, 2026","bullets":["Presentation and Q&A session on Wednesday, August 5, 2026 at 4:30 p.m. ET.","Webcast link and replay available on Ginkgo's investor relations website.","Shareholders can submit questions via X (#GinkgoResults) or email to investors@ginkgobioworks.com."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-26-051041","json":"https://secwatch.observer/filing/0001628280-26-051041.json","markdown":"https://secwatch.observer/filing/0001628280-26-051041.md","text":"https://secwatch.observer/filing/0001628280-26-051041.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1830214/000162828026051041/0001628280-26-051041-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1830214/000162828026051041/dna-20260730.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-30T20:07:34.148728+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}